Koplin Julian J
Monash University, Melbourne, Victoria, Australia.
J Med Philos. 2017 Nov 15;42(6):653-669. doi: 10.1093/jmp/jhx023.
Luke Semrau argues that the documented harms of existing organ markets do not undermine the case for establishing regulated systems of paid kidney donation. He offers two arguments in support of this conclusion. First, Semrau argues that the harms of kidney selling are straightforwardly amenable to regulatory solution. Second, Semrau argues that even in existing black markets, sellers would likely have experienced greater harm if the option of selling a kidney were not available. This commentary challenges both of Semrau's claims. I argue that there is no reason to believe that kidney sellers benefit from the current black market trade in organs, and highlight a number of potential issues regarding the effectiveness and feasibility of Semrau's proposed market regulations.
卢克·塞姆劳认为，现有器官市场所记录的危害并不能削弱建立有偿肾脏捐赠监管体系的理由。他提出了两个论据来支持这一结论。首先，塞姆劳认为，肾脏买卖的危害可直接通过监管解决。其次，塞姆劳认为，即使在现有的黑市中，如果没有出售肾脏的选择，卖家可能会遭受更大的伤害。这篇评论对塞姆劳的这两个观点都提出了质疑。我认为，没有理由相信肾脏卖家能从当前的器官黑市交易中获益，并强调了塞姆劳提议的市场监管在有效性和可行性方面的一些潜在问题。
